Press release: EU supports research on poorly understood diseases
Thanks to the dedicated work of Belgian Member of the European Parliament (MEP) Pascal Arimont and colleagues, Horizon Europe will provide new funding opportunities for research on high-burden, under-researched diseases.
While modern medicine has produced many spectacular breakthroughs, some diseases remain poorly understood to this day. These illnesses often cause chronic pain and debilitating fatigue for which doctors have little to offer.
A notable example is the illness Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) which affects approximately 2 million European citizens. ME/CFS is characterized by severe energy impairment, post-exertional malaise, cognitive dysfunction, and many other symptoms. It often causes severe disability and can leave patients bedridden for years.
Evelien Van Den Brink, a 38-year-old patient from the Netherlands has been living with ME/CFS for 24 years. Like many ME/CFS patients her illness started with an infection from which she never fully recovered. In the quarter of a century in which Van Den Brink has suffered from ME/CFS, scientific research has made disappointingly little headway. There are still no biomarkers, diagnostic tests, or effective treatments for the illness.
More at link: https://europeanmecoalition.com/press-release-eu-supports-research-on-poorly-understood-diseases/
Thanks to the dedicated work of Belgian Member of the European Parliament (MEP) Pascal Arimont and colleagues, Horizon Europe will provide new funding opportunities for research on high-burden, under-researched diseases.
While modern medicine has produced many spectacular breakthroughs, some diseases remain poorly understood to this day. These illnesses often cause chronic pain and debilitating fatigue for which doctors have little to offer.
A notable example is the illness Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) which affects approximately 2 million European citizens. ME/CFS is characterized by severe energy impairment, post-exertional malaise, cognitive dysfunction, and many other symptoms. It often causes severe disability and can leave patients bedridden for years.
Evelien Van Den Brink, a 38-year-old patient from the Netherlands has been living with ME/CFS for 24 years. Like many ME/CFS patients her illness started with an infection from which she never fully recovered. In the quarter of a century in which Van Den Brink has suffered from ME/CFS, scientific research has made disappointingly little headway. There are still no biomarkers, diagnostic tests, or effective treatments for the illness.
More at link: https://europeanmecoalition.com/press-release-eu-supports-research-on-poorly-understood-diseases/